Sources MOUNJARO (tirzepatide) Injection, for subcutaneous use (2022) Zepbound (tirzepatide) Injection, for subcutaneous use (2022) FDA News Release: FDA Approves First Medication for Obstructive Sleep Apnea (December 20, 2024) Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (June 21, 2024)
Cys 2 ), cystine-free (Cys 2 -free), or cystine-free/GSH-supplemented (750 M) medium for the indicated timepoints were determined
Peptides and peptide aggregates can trigger immune responses, but the likelihood for a specific preparation depends on sequence, purity, formulation, route, storage, patient factors, and repeated exposure
ZieglerDRRibeiroLCHagennMSiqueiraIRAraujoETorresILet alKetogenic diet increases glutathione peroxidase activity in rat hippocampus